A phase II multi-center study of triple therapy with paclitaxel, S-1 and cisplatin in patients with advanced gastric cancer. - Wikidata - wikimedia - TriplyDB

A phase II multi-center study of triple therapy with paclitaxel, S-1 and cisplatin in patients with advanced gastric cancer.

A phase II multi-center study of triple therapy with paclitaxel, S-1 and cisplatin in patients with advanced gastric cancer.

http://www.wikidata.org/entity/Q33395721

about

The use of lentinan for treating gastric cancer Lentinan prolonged survival in patients with gastric cancer receiving S-1-based chemotherapy Neoadjuvant chemotherapy followed by surgery versus surgery alone for gastric carcinoma: systematic review and meta-analysis of randomized controlled trials Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development.Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study.Chemo-Immunotherapy Using Lentinan for the Treatment of Gastric Cancer with Liver Metastases.A phase I study of triplet combination chemotherapy of paclitaxel, cisplatin and S-1 in patients with advanced gastric cancer.Comparison of FOLFOX and DOF regimens as first-line treatment in East Asian patients with advanced gastric cancer.

P2860

Q24619416-504E2A45-AB25-4C7F-9D3D-C9B49F9CFFC4 Q24635111-C292DA82-3863-4142-86E3-D588D9B75D44 Q31150068-AE912A1C-D63B-4221-9675-A21E0011BF22 Q37947984-073D5184-F467-49DD-87EE-EFA68882C064 Q38420500-3C81984A-8EA3-4B7D-8F86-8B4E1E1BEB36 Q42705635-0B5DDFEB-6A06-435B-86EC-E71FA0E802DE Q46396714-1A84AA98-C57B-4F78-8E42-4BA5DBA49570 Q49337286-039968AC-60C3-4FA4-BF94-5D5A31B2A80E

P2860

A phase II multi-center study of triple therapy with paclitaxel, S-1 and cisplatin in patients with advanced gastric cancer.

http://www.wikidata.org/entity/Q33395721

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

A phase II multi-center study ...... with advanced gastric cancer.

@ast

A phase II multi-center study ...... with advanced gastric cancer.

@en

type

label

A phase II multi-center study ...... with advanced gastric cancer.

@ast

A phase II multi-center study ...... with advanced gastric cancer.

@en

prefLabel

A phase II multi-center study ...... with advanced gastric cancer.

@ast

A phase II multi-center study ...... with advanced gastric cancer.

@en

P1433

Q33395721-714B6559-A42A-4264-9D71-D25214E1E6D1

P1476

Q33395721-4AD5AFEB-5AEC-4AA1-BDAD-5E071339B8CB

P2093

Q33395721-12542D31-13CF-4CC8-8B6C-D315A5D0F3CC

Q33395721-1BB27189-F22F-4915-A793-27AC566AADC5

Q33395721-20B0F933-94FD-4737-BFBD-F12B6AEBD38E

Q33395721-30D2859E-ACE4-43F7-A88C-16A43923665F

Q33395721-6DC94B76-7CCE-4EE0-BC2D-DEA4F95E8EBC

Q33395721-7540F3AC-D2EC-4EFB-9052-772110D7A3AC

Q33395721-87446181-D4B2-4B76-838E-ED40E93A011F

Q33395721-B2E3D788-E493-455B-9F1A-B127FFC75FA3

Q33395721-EB0102C7-480C-442E-9DF2-CAFB45806045

P2860

Q33395721-0DA4DFB2-C1D8-44C3-9718-B15A30AFC535

Q33395721-1CDEFA80-5003-4C43-BB90-2EF41EE180F1

Q33395721-36ABF701-DAB2-4071-AAEA-78FD63DC809A

Q33395721-3903FA33-E32A-4672-9B96-700C445FCA4D

Q33395721-45C71D3E-123A-4812-8BF4-6D6C2AF1086A

Q33395721-49C4DD73-9110-4E86-8FB5-66ECE1ACF54B

Q33395721-703DC2FC-1657-430B-9249-D65937323F44

Q33395721-82210049-DE40-4FC4-8AE2-794C6714D461

Q33395721-8EDD89BF-75F1-47B1-ADF9-39B4B2E83F8F

Q33395721-8FA95153-6657-44B6-B518-9D891ABD0447

P304

Q33395721-F72EA5F3-E41E-45FA-8355-CEF80E3E2B77

P31

Q33395721-7FCC1BC0-5EF2-41B2-8C0C-1945F140DD82

P356

Q33395721-ECBC592F-0D19-4B7C-9F60-640DF07873F0

P433

Q33395721-A766B9EA-E1CC-4D7E-93F6-479D74575C4D

P478

Q33395721-67B20AAB-7FE2-4625-AD75-31FA8A82B1DB

P577

Q33395721-56C849AC-7E27-4A8D-A98E-97D422BD30D2

P698

Q33395721-D4879055-DF3F-47C4-9D0A-24D9B7ED2F5B

P356

P1433

P1476

A phase II multi-center study ...... with advanced gastric cancer.

@en

P2093

H Goto

http://www.w3.org/2001/XMLSchema#string

H Iwase

http://www.w3.org/2001/XMLSchema#string

J Haruta

http://www.w3.org/2001/XMLSchema#string

K Ina

http://www.w3.org/2001/XMLSchema#string

M Shimada

http://www.w3.org/2001/XMLSchema#string

M Shinoda

http://www.w3.org/2001/XMLSchema#string

M Sugihara

http://www.w3.org/2001/XMLSchema#string

T Kumada

http://www.w3.org/2001/XMLSchema#string

T Tsuzuki

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2002

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data.

Dose-dense cisplatin/paclitaxel. a well-tolerated and highly effective chemotherapeutic regimen in patients with advanced ovarian cancer.

Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy.

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial.

Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).

New perspectives in the treatment of advanced or metastatic gastric cancer.

P304

76-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000328746

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21659786

http://www.w3.org/2001/XMLSchema#string